APA Цитирование

Rosar, F., Krause, J., Bartholomä, M., Maus, S., Stemler, T., Hierlmeier, I., . . . Khreish, F. (2021). Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis. Pharmaceutics.

Chicago-стиль цитирования

Rosar, Florian, Jonas Krause, Mark Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Samer Ezziddin, and Fadi Khreish. "Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients With Highly Advanced MCRPC With Poor Prognosis." Pharmaceutics 2021.

MLA-цитирование

Rosar, Florian, et al. "Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients With Highly Advanced MCRPC With Poor Prognosis." Pharmaceutics 2021.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.